Drug Index

Dexlansoprazole

Mechanism :

Proton pump inhibitor; decreases acid secretion in gastric parietal cells through inhibition of (H+, K+)-ATPase enzyme system.


Indication :

  • GERD
  • Erosive esophagitis

Contraindications :

Known hypersensitivity to dexlansoprazole or any component of the formulation; concomitant use with products that contain rilpivirine.


Dosing :

≥12 years of age.
GERD:
30 mg once daily for 4 weeks orally.
Erosive esophagitis:
Healing: 60 mg once daily for up to 8 weeks, Maintenance: 30 mg orally once daily for upto 16 weeks.

Adverse Effect :

Abdominal pain, diarrhea, flatulence, abdominal distress and tenderness, Barrett esophagus, angina pectoris, bradycardia, arrhythmias, chest pain, DVT, hypertension, headache, dizziness, falling, psychomotor agitation, anemia, thrombocytopenia, abnormal hepatic functions tests.


Interaction :

Clopidogrel: Dexlansoprazole may decrease serum concentrations of the active metabolite(s) of Clopidogrel.
Dasatinib: Proton Pump Inhibitors may decrease the serum concentration of Dasatinib.
Iron Salts: Proton Pump Inhibitors may decrease the absorption of Iron Salts.
Methotrexate: Proton Pump Inhibitors may increase the serum concentration of Methotrexate.
Voriconazole: May increase the serum concentration of Proton Pump Inhibitors. Proton Pump Inhibitors may increase the serum concentration of Voriconazole.



Hepatic Dose :

Mild hepatic impairment: No dose adjustment required.
Moderate hepatic impairment: Do not use more than 30 mg PO daily.
Severe hepatic impairment: Avoid use.
06/05/2024 08:44:27 Dexlansoprazole
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0